Integrated Filing — IndAS



General information about company

Scrip Code 506109
NSE Symbol GENESYS
MSEI Symbol NOTLISTED
ISIN INE727B01026
Name of company Genesys International Corporation Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-11-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Geographical information system
Start date and time of board meeting 13-11-2026   17:00:00
End date and time of board meeting 13-11-2026   18:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-02-2025
Indicate Company website link for updated RPT policy of the Company www.igenesys.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on loans



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 7,779.81 15,437.36
Other income 221.29 405.31
Total income 8,001.10 15,842.67
2 Expenses
(a) Cost of materials consumed 3,875.34 7,096.89
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 1,290.78 2,748.45
(e) Finance costs 342.74 656.34
(f) Depreciation, depletion and amortisation expense 1,122.24 2,270.40
(f) Other Expenses
1 Others 642.16 1,320.27
Total other expenses 642.16 1,320.27
Total expenses 7,273.26 14,092.35
3 Total profit before exceptional items and tax 727.84 1,750.32
4 Exceptional items 0.00 0.00
5 Total profit before tax 727.84 1,750.32
6 Tax expense
7 Current tax 232.92 560.11
8 Deferred tax (33.96) (56.93)
9 Total tax expenses 198.96 503.18
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 528.88 1,247.14
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 528.88 1,247.14
17 Other comprehensive income net of taxes 57.72 65.20
18 Total Comprehensive Income for the period 586.60 1,312.34
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,343.23 3,343.23
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.6 2.31
Diluted earnings (loss) per share from continuing operations 0.6 2.31
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.6 2.31
Diluted earnings (loss) per share from continuing and discontinued operations 0.6 2.31
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1.Notes to The unaudited Standalone financial results of Genesys International Corporation Limited ('GICL') (the Company) have been prepared In accordance with the Indian Accounting Standards (lnd AS), notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules there under and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 as amended. 2.The unaudited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 13 November 2026. These unaudited standalone financial results have been subjected to limited review by the statutory auditors of the Company and they have expressed an unmodified rev1ew conclusion on these unaudited standalone financial results. The above unaudited financial results of the Company are available on the Company's website (www.1genesys.com.com} and stock exchanges websites, BSE (www.bselndia.com} and NSE (www.nselndia.com), where the shares of the Company are listed. 3.On 17th May 2025, the Company has, by way of Qualified Institutional Placement (QIP) In accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and section 42 and 62 of the Companies Act, 2013, allotted 17, 39,625 equity shares of face value of Rs. 5 per share at a price of Rs. 632.32 per share, aggregating to Rs.11,000 lakhs. The utlisation of QIP funds till 30th Sept 26 was 4561.04 Lakhs with a balance outstanding of Rs.6438.96 Lakhs. During the quarter, the QIP funds withdrawn have been utilized in accordance with the 'Use of Proceeds' mentioned in the placement document of QIP except for an amount of Rs. 660 lakhs which was utilised for purposes other than those specified in the offer document, which has been transferred back to the monitoring account from the current account during the quarter. During the period, in AGM conducted on 30th Sept 2026, the Company proposed to revise the objects of utilisation of the QIP proceeds, In accordance with the applicable regulatory and statutory requirements. Out of the balance 6438.96 Lakhs, an amount of Rs.2438.96 Lakhs will be utilised towards continued development of the technology platform and creation/updation of map content as originally planned with an extension till March 2028. Further, the balance of Rs.4000 Lakhs is proposed towards repayment of bank Loan which is expected to reduce the Company's outstanding borrowings. 4.The figures for the quarter ended 30 September 2026is the balancing figures between unaudited figures in respect of the half financial year and the unaudited published year to date figures up to quarter ended 30 June 2026 which were subject to limited review by the statutory auditors. 5.The Company operates only m one Primary Segment I.e. GIS based services, hence disclosure as per IND AS 108 'Operating Segment' is not required. 6.Pursuant to the Board of Directors approval dated June 26, 2026 for issue of equity shares by way of Rights Issue (Rights Issue), the Company had filed Letter of Offer on July 31, 2026. The Rights Issue Committee of the Board ot Directors, approved the terms ot the rights issue, including the Issue price of Rs 50 per fully paid-up equity share (including a premium of Rs 45 per equity share), the rights entitlement ratio of 3 (Three) fully paid-up equity shares for every 5 (Five) tully paid-up equity shares held by the eligible equity shareholders of the Company as on the record date, and an aggregate Issue of up to 2,50,74,226fully paid-up equity shares aggregating to approximately Rs.12537 Lakhs. The record date for determining the eligibility of shareholders was fixed as 6 August 2026, and the rights issue opened on 14 August 2026 and closed on 21 August 2026. As per the objects of the issue, the company has raised an amount of Rs.11048 Lakhs and an amount of Rs.1489lakhs was adjusted towards extinguishment of unsecured Loan of promoter. 7.Previous period figures have been re-grouped I re-classified, wherever necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,716.01
Capital work-in-progress 55.73
Investment property 0.00
Goodwill 0.00
Other intangible assets 8,232.22
Intangible assets under development 12,310.36
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 13,647.16
Trade receivables, non-current 0.00
Loans, non-current 21.20
Other non-current financial assets
1 other financial assets 3,439.93
Total of other non-current financial assets 3,439.93
Total non-current financial assets 17,108.29
Deferred tax assets (net) 1,007.83
Other non-current assets
1 Other non-current assets 911.31
Total of other non-current assets 911.31
Total non-current assets 44,341.75
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 14,255.00
Cash and cash equivalents 321.42
Bank balance other than cash and cash equivalents 3,630.40
Loans, current 451.43
Other current financial assets
Total of other current financial assets 52,270.44
Total current financial assets 70,928.69
Current tax assets (net) 204.93
Other current assets
1 Other current assets 2,017.25
Total of other current assets 2,017.25
Total current assets 73,150.87
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,17,492.62
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,343.23
Other equity 85,506.96
Total equity attributable to owners of parent 88,850.19
Non controlling interest
Total equity 88,850.19
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2,200.57
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 lease liabilities 617.45
Total of other non-current financial liabilities 617.45
Total non-current financial liabilities 2,818.02
Provisions, non-current 1,177.29
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 3,995.31
Current liabilities
Current financial liabilities
Borrowings, current 13,186.63
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 968.69
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,727.85
Total Trade payable 6,696.54
Other current financial liabilities
1 lease liabilities 565.83
2 Other Financial Liabilities 2,154.75
Total of other current financial liabilities 2,720.58
Total current financial liabilities 22,603.75
Other current liabilities 568.58
1 Other current liabilities 568.58
Total of other current liabilities 568.58
Provisions, current 364.41
Current tax liabilities (Net) 1,110.38
Deferred government grants, Current 0.00
Total current liabilities 24,647.12
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 28,642.43
Total equity and liabilites 1,17,492.62
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plans (net of taxes) 57.72 65.20
Total Amount of items that will not be reclassified to profit and loss 57.72 65.20
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 57.72 65.20



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,750.32
Adjustments for reconcile profit (loss)
Adjustments for finance costs 656.34
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current (396.03)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,276.69)
Adjustments for decrease (increase) in other non-current assets (49.20)
Adjustments for other financial assets, non-current 48.26
Adjustments for other financial assets, current (10,494.23)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 2,896.97
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 257.54
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,270.40
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 89.77
Adjustments for provisions, non-current (130.51)
Adjustments for other financial liabilities, current 17.62
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (74.36)
Adjustments for dividend income 0.00
Adjustments for interest income 323.32
Adjustments for share-based payments 90.11
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 539.18
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (5,878.15)
Net cash flows from (used in) operations (4,127.83)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 187.50
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (4,315.33)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,032.43
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets (216.99)
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 1,321.77
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 258.06
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (5,427.21)
Net cash flows from (used in) investing activities (7,306.36)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 12,537.11
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options (35.50)
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings (2,358.15)
Repayments of borrowings (1,727.93)
Payments of lease liabilities 168.00
Dividends paid 0.00
Interest paid 581.49
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 11,121.90
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (499.79)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (499.79)
Cash and cash equivalents cash flow statement at beginning of period 821.22
Cash and cash equivalents cash flow statement at end of period 321.43





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 17-05-2025
Amount Raised 11,000.00
Report filed for Quarter ended 30-09-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised Yes
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders No
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation During Q2 FY27, the company transferred issue proceeds of Rs. 6.60 crore from the MA account to the current account. As the intended purpose for which the funds were transferred was not utilised, the company has transferred the abovementioned Rs. 6.60 crore back to the MA account from the current account before the end of the quarter.
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Setting up of data centre No 1,770.50 0.00 285.00 0.00
2 Development of tech platform No 2,574.22 0.00 1,035.01 0.00
3 Creation/updation of map content No 1,865.16 0.00 583.07 0.00
4 Building sensor capacity No 1,056.83 0.00 0.00 0.00
5 Strengthening information technology infrastructure No 983.34 0.00 67.17 0.00
6 General corporate purposes No 2,049.15 0.00 2,045.00 0.00
7 Issue Expenses No 700.80 0.00 646.98 0.00


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)

Amount in (Lakhs)

Mode of Fund Raising Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 24-08-2026
Amount Raised 12,537.11
Report filed for Quarter ended 30-09-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding working capital requirements of the Company No 8,800.00 0.00 2,597.88 0.00
2 Adjustment of unsecured loans of the promoter through conversion of part of the outstanding loan to equity shares against his rights equity shares No 1,489.00 0.00 1,489.00 0.00
3 General Corporate Purpose No 2,132.16 0.00 0.00 0.00
4 Issue Expenses No 115.95 0.00 84.90 0.00


Signatory Details

Name of signatory RAVI KUMAR JATAVALLABHA
Designation of person Chief Financial Officer
Place MUMBAI
Date 13-11-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 60.00 0.00 3.00
2 Genesys International Corporation Limited Ms. Bharti Sinha Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 1.30 0.00 0.00
3 Genesys International Corporation Limited Mr. Ajay Harish Aggarwal Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 1.30 0.00 0.00
4 Genesys International Corporation Limited Dr. Yogita Shukla Non executive Non Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.75 0.00 0.00
5 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.50 0.00 0.00
6 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Consultancy Fees 60.00 approved by the Audit committee 30.00 4.50 22.50
7 Genesys International Corporation Limited Mrs. Sunita Hemrajani Relative of Director Any other transaction Consultancy Fees 60.00 approved by the Audit committee 30.00 4.34 22.34
8 Genesys International Corporation Limited AddGeo Foundation Company in which Common Directorship Any other transaction Consultancy Fees 12.00 approved by the Audit committee 4.93 0.00 0.00
9 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Remuneration not applicable 11.54 1.63 1.62 Textual Information(1)
10 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Any other transaction ESOP Expense not applicable 2.07 0.00 0.00 Textual Information(2)
11 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Remuneration not applicable 62.27 6.31 6.89
12 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction advance adjusted 10.00 approved by the Audit committee 1.31 2.41 1.10 Advance 0 3 years Unsecured Salary advance
13 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction ESOP Expense not applicable 0.00 0.00 0.00
14 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan Received 3,000.00 approved by the Audit committee 2,230.00 2,225.00 1,855.57 Loan 0 Repayable on demand Unsecured Working capital
15 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan repaid 3,000.00 approved by the Audit committee 2,599.42 2,225.00 1,855.57 Loan 0 Repayable on demand Unsecured Working capital
16 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan Received 2,500.00 approved by the Audit committee 1,030.00 2,050.00 475.00 Loan 0 Repayable on demand Unsecured Working capital
17 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan repaid 2,500.00 approved by the Audit committee 2,605.00 2,050.00 475.00 Loan 0 Repayable on demand Unsecured Working capital
18 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Interest payable 237.60 approved by the Audit committee 6.34 0.59 4.88 Loan 12.00 Repayable on demand Unsecured Working capital
19 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction loan repaid 1,980.00 approved by the Audit committee 800.00 400.00 300.00 Loan 12.00 Repayable on demand Unsecured Working capital
20 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 7,399.40 7,399.40
21 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Loan not applicable 700.00 388.75 452.37 Loan 8.00 3 years Unsecured Working capital
22 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction loan returned not applicable 631.93 388.75 452.37 Loan 8.00 3 years Unsecured Working capital
23 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Interest received not applicable 25.04 24.11 25.62
24 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction Project expense not applicable 621.36 285.51 98.85
25 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Sale of goods or services not applicable 312.61 2,225.78 497.96
26 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Investment not applicable 0.00 312.37 312.37
27 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Any other transaction Provision for impairment of Investments 8,569.79 approved by the Audit committee 0.00 8,569.79 8,569.79
28 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 14,505.18 14,505.18
29 Genesys International Corporation Limited Late Mrs. Saroja Siraj Malik Whole-time Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 0.00 0.32 0.32
30 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Loan received 1,980.00 approved by the Audit committee 700.00 400.00 300.00 Loan 12.00 Repayable on demand Unsecured Working capital
31 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Loan received 2,000.00 approved by the Audit committee 1,055.00 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
32 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Loan repaid 2,000.00 approved by the Audit committee 1,055.00 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
33 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Interest payable approved by the Audit committee 0.85 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
34 Genesys International Corporation Limited Mr. Sumit Sen Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 1.45 0.00 0.00
35 Genesys International Corporation Limited Mr. Nikhil Alulkar Chief Executive Officer Remuneration not applicable 32.10 0.00 11.45
36 Genesys International Corporation Limited Mr. Nikhil Alulkar Chief Executive Officer Any other transaction Consultancy Fees not applicable 7.39 0.00 0.00
Total value of transaction during the reporting period 14,619.46



Text Block

Textual Information(1) Company Secretary with effect from 1st June 2025
Textual Information(2) Company Secretary with effect from 1st June 2025